CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE114.850 (0 %)
PREV CLOSE ( ) 114.85
OPEN PRICE ( ) 114.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7000
TODAY'S LOW / HIGH ( )114.85 114.85
52 WK LOW / HIGH ( ) 80160
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 10-03 2003
Management Info
Hemant Chandravadan Bhagat - Chairman Hemant Chandravadan Bhagat - Managing Director
Registered Office

Address Flat No. 1 & 2, Gr. Floor, 323,F, Bhagat Bhuvan Dr. Ambedkar Road,Matunga (East),
Mumbai,
Maharashtra-400019

Phone 022-24146154 / 24157205 / 24129162

Email info@cbcpharma.net, export@cbcpharma.net

Website www.cbcpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS
18Nov Chandra Bhagat Pharma informs about pr
Chandra Bhagat Pharma has informed that the 18th Annual General Meeting..
21Oct Chandra Bhagat Pharma informs about ou
Chandra Bhagat Pharma has informed that the Board of Directors of the Co..
01Oct Chandra Bhagat Pharma informs about cl
In Accordance with code of Internal Procedure and Conduct of Regulating,..
22Jun Chandra Bhagat Pharma informs about bo
Chandra Bhagat Pharma has informed that meeting of the Board of Director..
30Jan Chandra Bhagat Pharma coming with an I
Chandra Bhagat Pharma Chandra Bhagat Pharma is coming out with is coming..
Financials
Rs. in Millions
QTR ANNUAL 23
Net Profit9.0400000000001
Gross Profit 11.6100000000001
Operating Profit 36.1400000000001
Net Sales 1196.72
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 7600.75 (5.52%)
M.Cap (Rs. in Cr)9751.68
Procter&Gamble Healt (BSE)
 4916.35 (2.97%)
M.Cap (Rs. in Cr)8160.84
Abbott India (BSE)
 26415.75 (0.53%)
M.Cap (Rs. in Cr)56131.62
Pfizer (BSE)
 4253.30 (1.13%)
M.Cap (Rs. in Cr)19457.88
Sanofi India (BSE)
 8324.10 (0.51%)
M.Cap (Rs. in Cr)19170.92
Shareholding Pattern
PROMOTERS 68.77%
NON-INSTITUTION 29.01%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.